nrclinonc
Post on 22-Jan-2016
39 Views
Preview:
DESCRIPTION
Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis. Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapy Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175. - PowerPoint PPT Presentation
TRANSCRIPT
Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis
Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapyNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175
top related